Nestlé Health Science and Codexis extends gut disorder partnership 14-Jan-2020 By Will Chu Nestlé Health Science and Codexis are to extend a gut health-focused pact that sees the two firms continue to develop a lead candidate to address the gastrointestinal (GI) disorder phenylketonuria.
